RituximabKifunensineAlfi0894inon-small cell lung cancerNSCLC
…nd with low uM affinity to the Fc receptor FcGRIIIa, similar to Rituximab.Conclusions We demonstrate the feasibility of using an Fc-fusio…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 1,201–1,260 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
hydroxocobalamin3infigratinib3ketoconazole3lazertinib3modafinil3montelukast3nirmatrelvir/ritonavir3prophylactic antibiotics3psilocybin-assisted3rifampin3rosiglitazone3selpercatinib3vitamins35-Aminosalicylic acid3Afamitresgene autoleucel3Alprostadil3Atezolizumab-Bevacizumab3Azithromycin-resistant3ChatGPT3Cholic acid3DTG-based3Depot medroxyprogesterone acetate3Erythromycin3FDG3IPI3IV diuretics3Indocyanine green3Infliximab-related3Lanreotide3Liposomal irinotecan3MART3NaCl3ONPs3Onyx 183Piperacillin3Poly-ICLC3Psychoanaleptics3RNAP33Ro523Sufentanyl3Tyramide3VKAs3Vitamin K3anticonvulsants3antiplatelet agents3blood products3cefuroxime3dasatinib3dexchlorpheniramine3docetaxel-induced3embolic agents3fludrocortisone3folate3human albumin solution3imrecoxib3insulin aspart3insulin-treated3mABs3oral corticosteroid3oral prednisolone3
Articles mentioning drugs
10,506 articles · page 366 of 876PROTACanti-PD-1 antibodymelanomaArvinas Animal Care and Use Committee
…munogenic, immune checkpoint blockade-resistant melanoma model, PROTAC HPK1 degraders elicited superior TGI (79%) vs an anti-PD-1 anti…
ChAdOx1glioblastomaUniversity of Oxford
…a murine tumor-associated antigen (TAA), which we targeted with ChAdOx1/MVA-P1A vaccines. Furthermore, we developed a pipeline to ident…
nivolumabcabozantinibimCORE Grant 142583Hepatocellular carcinoma (HCC)Johns HopkinsEthicsNeoadjuvant strategiesNCT03299946
…tor cabozantinib and the anti-PD-L1 immune checkpoint inhibitor nivolumab in patients with unresectable HCC ( NCT03299946). Major patholo…
IFN-γIFN-γ-signalingIFN-γ-dependentIFN-gamma-DependentBreast CancerVirginia Commonwealth Universitylung metastatic disease
…ation of tumor-associated macrophages (TAMs) via suppression of IFN-γ.5–8 Here, we investigate whether immune suppression mediated by…
ICIsimmune checkpoint inhibitorscutaneous melanomabladder cancerlung cancersimmunotherapyImmunotherapy-related
…m multiple independent cohorts, including patients treated with ICIs, collected via whole-exome sequencing and targeted sequencing. …
aDR5aDR5-expressingDR5hematological malignanciessolid tumorsCAR-T therapyAssociation for Assessment of Laboratory Animal Care
…engineered CAR-T cells to express a membrane-bound DR5 agonist (aDR5) lacking intracellular signaling capabilities to induce apoptos…
UCCT-BCMA-1OPM2 multiple myelomamultiple myeloma
…d genomic stability and lack of oncogenic potential.Conclusions UCCT-BCMA-1 has successfully received IND-clearance to initiate Phase-I cli…
AZD6422CLDN18.2aCD20esophageal cancers
…reen S, Broggi, MAS, Hatke AL, et al. Preclinical evaluation of AZD6422, an armored chimeric antigen receptor T cell targeting CLDN18.2…
HaloCARhematologic cancerssolid tumorsChimeric Antigen Receptor (CAR) T cell therapy
… chloroalkane (CA) motif, the adaptors covalently attach to the HaloCAR, arming it to attack tumor cells.Methods We generated antibody-…
bezafibrateB cell malignanciesCAR T cell therapy
…the synergistic effects of a clinically approved PGC1α agonist, bezafibrate, in combination with CAR T cell therapy. This dual treatment dr…
98.3%
AB-3028mCRPCsolid tumorsTCGAhematological malignanciesmetastatic castration-resistant prostate cancer (mCRPC)The Cancer Genome Atlasprostate tumorsGTExChimeric Antigen Receptor T (CAR T) cell therapies
…al persistence.Methods To evaluate suitable target antigens for AB-3028, we first conducted a comprehensive in silico analyses with bul…